Colorectal Cancer Molecular Diagnostics Market Report 2026
Download Free Sample Buy Now
Colorectal Cancer Molecular Diagnostics Market Global Report 2026 Market Report Infographic Image
Item added to cart!

Published : February 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF
Purchase This Report

Colorectal Cancer Molecular Diagnostics Market Report 2026

Global Outlook – By Type (Instruments, Reagents And Kits, Services), By Technology (Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)), By End Users (Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Colorectal Cancer Molecular Diagnostics Market Overview

• Colorectal Cancer Molecular Diagnostics market size has reached to $2.78 billion in 2025

• Expected to grow to $4.15 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%

• Growth Driver: The Impact Of Increasing Colorectal Cancer Prevalence On The Colorectal Cancer Molecular Diagnostics Market

• Market Trend: Advancements in Non-Invasive Early Detection for Colorectal Cancer

• North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Colorectal Cancer Molecular Diagnostics Market?

Colorectal cancer, also known as colon cancer or rectal cancer, is a malignant tumor that develops in the colon (the large intestine) or the rectum (the final portion of the digestive tract just before the anus). It is a type of cancer that arises from the inner lining of these parts of the gastrointestinal system. Colorectal cancer molecular diagnostics uses advanced techniques to identify specific genetic mutations, alterations, and biomarkers that play a role in the development, progression, and treatment response of colorectal cancer.

The main types of colorectal cancer molecular diagnostics are instruments, reagents, kits, and services. An instrument refers to a specialized tool or device designed to analyze and detect molecular changes, such as genetic mutations, variations in gene expression, or specific biomolecules, within biological samples of colorectal cancer patients. The molecular diagnostic solutions are also based on technologies such as polymerase chain reaction (PCR), sequencing, mass spectrometry, transcription-mediated amplification, chips and microarrays, and isothermal nucleic acid amplification technology (INAAT) used by end users such as hospitals, ambulatory surgical centers, diagnostic laboratories, and homecare settings.

Colorectal Cancer Molecular Diagnostics Market Global Report 2026 Market Report bar graph

What Is The Colorectal Cancer Molecular Diagnostics Market Size and Share 2026?

The colorectal cancer molecular diagnostics market size has grown strongly in recent years. It will grow from $2.78 billion in 2025 to $3.02 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing colorectal cancer incidence rates, expansion of diagnostic laboratory infrastructure, rising adoption of molecular testing protocols, improved awareness of early screening, growing use of precision medicine approaches.

What Is The Colorectal Cancer Molecular Diagnostics Market Growth Forecast?

The colorectal cancer molecular diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.15 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing investments in precision oncology, rising demand for minimally invasive diagnostics, expansion of genomic testing programs, growing integration of ai in cancer diagnostics, increasing focus on treatment response monitoring. Major trends in the forecast period include increasing adoption of molecular biomarker testing, rising use of pcr and sequencing technologies, growing demand for personalized oncology diagnostics, expansion of companion diagnostic development, enhanced focus on early cancer detection.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Colorectal Cancer Molecular Diagnostics Market Segmentation

1) By Type: Instruments, Reagents And Kits, Services

2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)

3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings

Subsegments:

1) By Instruments: PCR Machines, Sequencers, Microarrays

2) By Reagents And Kits: DNA Or RNA Extraction Kits, Assay Kits, Reagent Packs

3) By Services: Diagnostic Testing Services, Genetic Testing Services, Consultation Services

What Is The Driver Of The Colorectal Cancer Molecular Diagnostics Market?

The rising prevalence of colorectal cancer is expected to propel the growth of the colorectal cancer molecular diagnostics market going forward. Colorectal cancer is a disease that affects the colon or rectum, which are parts of the digestive system. Colorectal cancer occurs when cells in the colon or rectum grow out of control and form a tumor. The increase in colorectal cancer increases the demand for molecular diagnostics for cancer detection and treatment. For instance, in March 2023, according to the American Cancer Society, a US-based nationwide voluntary health organization dedicated to eliminating cancer, roughly 153,020 people are expected to receive a diagnosis of CRC (colorectal cancer), and out of that number, approximately 52,550 individuals are projected to succumb to the disease. Among those affected, there will be 19,550 cases and 3,750 deaths occurring in individuals under the age of 50. Therefore, the rising prevalence of colorectal cancer is driving the growth of the colorectal cancer molecular diagnostics industry.

Key Players In The Global Colorectal Cancer Molecular Diagnostics Market

Major companies operating in the colorectal cancer molecular diagnostics market are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.

Global Colorectal Cancer Molecular Diagnostics Market Trends and Insights

Major companies operating in the colorectal cancer molecular diagnostics market are focusing on developing innovative solutions, such as blood-based liquid biopsy screening tests, to meet the rising demand for non-invasive, early detection tools, improved patient compliance versus colonoscopy, and broader population screening as guidelines and reimbursement evolve. A liquid biopsy is a blood test that detects tumour-derived biomarkers from a simple blood draw; its key features include minimal invasiveness, the ability to screen asymptomatic populations, and molecular-level sensitivity that complements. For instance, in July 2024, Guardant Health, a United States-based precision oncology company, launched Shield, a blood-based colorectal cancer screening test that was approved by the U.S. Food and Drug Administration as a primary screening option for average-risk adults 45 and older. Shield is a multi-marker blood assay that analyses circulating tumour signals to identify people likely to have colorectal cancer; it was developed and validated in the large ECLIPSE clinical programme and demonstrated high sensitivity and specificity sufficient for FDA primary-screening designation. The test’s composition and functionality combine sequencing and proprietary bioinformatic classifiers to detect methylation and other tumour-derived signals in plasma. Its unique features include convenience (single blood draw), potential to increase screening uptake, and a pathway to Medicare coverage, and its applications are population screening and triage to diagnostic colonoscopy for positives, offering earlier detection with fewer invasive procedures.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Colorectal Cancer Molecular Diagnostics Market?

In July 2023, New Day Diagnostics LLC, a US-based medical equipment manufacturing company, acquired the assets of Epigenomics AG for an undisclosed amount. With this acquisition, New Day Diagnostics broadens its offerings within cancer diagnostics, overtaking intellectual property belonging to Epigenomics AG, including Epi ProColon, a screening technology aimed at the non-invasive identification of colorectal cancer. Epigenomics AG is a Germany-based colorectal cancer molecular diagnostics company.

Regional Outlook

North America was the largest region in the colorectal cancer molecular diagnostics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Colorectal Cancer Molecular Diagnostics Market?

The colorectal cancer molecular diagnostics market consists of revenues earned by entities by providing diagnostic genetic mutation analysis, biomarker profiling, and epigenetic analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The colorectal cancer molecular diagnostics market consists of sales of molecular diagnostic biochips, liquid biopsy kits, and bioinformatics software. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Colorectal Cancer Molecular Diagnostics Market Report 2026?

The colorectal cancer molecular diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the colorectal cancer molecular diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Colorectal Cancer Molecular Diagnostics Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $3.02 billion
Revenue Forecast In 2035 $4.15 billion
Growth Rate CAGR of 8.5% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Type, Technology, End Users
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt.
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Colorectal Cancer Molecular Diagnostics Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Colorectal Cancer Molecular Diagnostics Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Colorectal Cancer Molecular Diagnostics Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Colorectal Cancer Molecular Diagnostics Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Artificial Intelligence & Autonomous Intelligence

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.2. Major Trends

4.2.1 Increasing Adoption Of Molecular Biomarker Testing

4.2.2 Rising Use Of Pcr And Sequencing Technologies

4.2.3 Growing Demand For Personalized Oncology Diagnostics

4.2.4 Expansion Of Companion Diagnostic Development

4.2.5 Enhanced Focus On Early Cancer Detection

5. Colorectal Cancer Molecular Diagnostics Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Diagnostic Laboratories

5.3 Ambulatory Surgical Centers

5.4 Oncology Clinics

5.5 Research Institutes

6. Colorectal Cancer Molecular Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Colorectal Cancer Molecular Diagnostics Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Colorectal Cancer Molecular Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Colorectal Cancer Molecular Diagnostics Market Size, Comparisons And Growth Rate Analysis

7.3. Global Colorectal Cancer Molecular Diagnostics Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Colorectal Cancer Molecular Diagnostics Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Colorectal Cancer Molecular Diagnostics Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Colorectal Cancer Molecular Diagnostics Market Segmentation

9.1. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Instruments, Reagents And Kits, Services

9.2. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)

9.3. Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings

9.4. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

PCR Machines, Sequencers, Microarrays

9.5. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

DNA Or RNA Extraction Kits, Assay Kits, Reagent Packs

9.6. Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Diagnostic Testing Services, Genetic Testing Services, Consultation Services

10. Colorectal Cancer Molecular Diagnostics Market Regional And Country Analysis

10.1. Global Colorectal Cancer Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Colorectal Cancer Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market

11.1. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Colorectal Cancer Molecular Diagnostics Market

12.1. China Colorectal Cancer Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Colorectal Cancer Molecular Diagnostics Market

13.1. India Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Colorectal Cancer Molecular Diagnostics Market

14.1. Japan Colorectal Cancer Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Colorectal Cancer Molecular Diagnostics Market

15.1. Australia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Colorectal Cancer Molecular Diagnostics Market

16.1. Indonesia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Colorectal Cancer Molecular Diagnostics Market

17.1. South Korea Colorectal Cancer Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Colorectal Cancer Molecular Diagnostics Market

18.1. Taiwan Colorectal Cancer Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Colorectal Cancer Molecular Diagnostics Market

19.1. South East Asia Colorectal Cancer Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Colorectal Cancer Molecular Diagnostics Market

20.1. Western Europe Colorectal Cancer Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Colorectal Cancer Molecular Diagnostics Market

21.1. UK Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Colorectal Cancer Molecular Diagnostics Market

22.1. Germany Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Colorectal Cancer Molecular Diagnostics Market

23.1. France Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Colorectal Cancer Molecular Diagnostics Market

24.1. Italy Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Colorectal Cancer Molecular Diagnostics Market

25.1. Spain Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Colorectal Cancer Molecular Diagnostics Market

26.1. Eastern Europe Colorectal Cancer Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Colorectal Cancer Molecular Diagnostics Market

27.1. Russia Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Colorectal Cancer Molecular Diagnostics Market

28.1. North America Colorectal Cancer Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Colorectal Cancer Molecular Diagnostics Market

29.1. USA Colorectal Cancer Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Colorectal Cancer Molecular Diagnostics Market

30.1. Canada Colorectal Cancer Molecular Diagnostics Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Colorectal Cancer Molecular Diagnostics Market

31.1. South America Colorectal Cancer Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Colorectal Cancer Molecular Diagnostics Market

32.1. Brazil Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Colorectal Cancer Molecular Diagnostics Market

33.1. Middle East Colorectal Cancer Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Colorectal Cancer Molecular Diagnostics Market

34.1. Africa Colorectal Cancer Molecular Diagnostics Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Segmentation By Technology, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Colorectal Cancer Molecular Diagnostics Market Regulatory and Investment Landscape

36. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape And Company Profiles

36.1. Colorectal Cancer Molecular Diagnostics Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Colorectal Cancer Molecular Diagnostics Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Colorectal Cancer Molecular Diagnostics Market Company Profiles

36.3.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis

37. Colorectal Cancer Molecular Diagnostics Market Other Major And Innovative Companies

Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc, Guardant Health, Luminex Corporation, GenMark Diagnostics

38. Global Colorectal Cancer Molecular Diagnostics Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Colorectal Cancer Molecular Diagnostics Market

40. Colorectal Cancer Molecular Diagnostics Market High Potential Countries, Segments and Strategies

40.1 Colorectal Cancer Molecular Diagnostics Market In 2030 - Countries Offering Most New Opportunities

40.2 Colorectal Cancer Molecular Diagnostics Market In 2030 - Segments Offering Most New Opportunities

40.3 Colorectal Cancer Molecular Diagnostics Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Colorectal Cancer Molecular Diagnostics Market, Overview Of Key Products - Product Examples
  • Table 2: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Colorectal Cancer Molecular Diagnostics Market, Supply Chain Analysis
  • Table 4: Global Colorectal Cancer Molecular Diagnostics Market, Major Raw Material Providers
  • Table 5: Global Colorectal Cancer Molecular Diagnostics Market, Major Resource Providers
  • Table 6: Global Colorectal Cancer Molecular Diagnostics Market, Major Manufacturers (Suppliers)
  • Table 7: Global Colorectal Cancer Molecular Diagnostics Market, Major Distributors And Channel Partners
  • Table 8: Global Colorectal Cancer Molecular Diagnostics Market, Key Technologies & Future Trends
  • Table 9: Global Colorectal Cancer Molecular Diagnostics Market, Major Trends
  • Table 10: Global Colorectal Cancer Molecular Diagnostics Market, Major End Users
  • Table 11: Global Colorectal Cancer Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Colorectal Cancer Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Colorectal Cancer Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Colorectal Cancer Molecular Diagnostics Market - TAM, US$ Billion, 2025
  • Table 15: Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Colorectal Cancer Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Colorectal Cancer Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Asia-Pacific, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Asia-Pacific, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Asia-Pacific, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: China, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: China, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: China, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: India, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: India, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: India, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: Japan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: Japan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: Japan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: Australia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Australia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Australia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Indonesia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Indonesia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Indonesia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: South Korea, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: South Korea, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: South Korea, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Taiwan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: Taiwan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: Taiwan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South East Asia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: South East Asia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: South East Asia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Western Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: Western Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: Western Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: UK, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: UK, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: UK, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Germany, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: Germany, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: Germany, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: France, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: France, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: France, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Italy, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: Italy, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: Italy, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: Spain, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Spain, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Spain, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Eastern Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Eastern Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Eastern Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Russia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Russia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Russia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: North America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: North America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: North America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: USA, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: USA, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: USA, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: Canada, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: Canada, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: Canada, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: South America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: South America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: South America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Brazil, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: Brazil, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: Brazil, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: Middle East, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Middle East, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Middle East, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Africa, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Africa, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Africa, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Global Colorectal Cancer Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 96: Global Colorectal Cancer Molecular Diagnostics Market - Company Scoring Matrix
  • Table 97: Johnson & Johnson Financial Performance
  • Table 98: Bayer AG Financial Performance
  • Table 99: Abbott Laboratories Financial Performance
  • Table 100: Danaher Corporation Financial Performance
  • Table 101: Becton Dickinson and Company Financial Performance
  • Table 102: Global Colorectal Cancer Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Table 103: Global Colorectal Cancer Molecular Diagnostics Market, Competitive Dashboard
  • Table 104: Global Colorectal Cancer Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 105: Global, Colorectal Cancer Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Table 106: Global, Colorectal Cancer Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Table 107: Global, Colorectal Cancer Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

List Of Figures

    Figure 1: Global Colorectal Cancer Molecular Diagnostics Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Colorectal Cancer Molecular Diagnostics Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Colorectal Cancer Molecular Diagnostics Market, Supply Chain Analysis
  • Figure 4: Global Colorectal Cancer Molecular Diagnostics Market, Major Raw Material Providers
  • Figure 5: Global Colorectal Cancer Molecular Diagnostics Market, Major Resource Providers
  • Figure 6: Global Colorectal Cancer Molecular Diagnostics Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Colorectal Cancer Molecular Diagnostics Market, Major Distributors And Channel Partners
  • Figure 8: Global Colorectal Cancer Molecular Diagnostics Market, Key Technologies & Future Trends
  • Figure 9: Global Colorectal Cancer Molecular Diagnostics Market, Major Trends
  • Figure 10: Global Colorectal Cancer Molecular Diagnostics Market, Major End Users
  • Figure 11: Global Colorectal Cancer Molecular Diagnostics Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Colorectal Cancer Molecular Diagnostics Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Colorectal Cancer Molecular Diagnostics Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Colorectal Cancer Molecular Diagnostics Market - TAM, US$ Billion, 2025
  • Figure 15: Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Reagents And Kits, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Colorectal Cancer Molecular Diagnostics Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Colorectal Cancer Molecular Diagnostics Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Colorectal Cancer Molecular Diagnostics Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Asia-Pacific, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Asia-Pacific, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Asia-Pacific, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: China, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: China, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: China, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: India, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: India, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: India, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: Japan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: Japan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: Japan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: Australia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Australia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Australia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Indonesia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Indonesia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Indonesia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: South Korea, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: South Korea, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: South Korea, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Taiwan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: Taiwan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: Taiwan, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South East Asia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: South East Asia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: South East Asia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Western Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: Western Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: Western Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: UK, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: UK, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: UK, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Germany, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: Germany, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: Germany, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: France, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: France, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: France, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Italy, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: Italy, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: Italy, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: Spain, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Spain, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Spain, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Eastern Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Eastern Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Eastern Europe, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Russia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Russia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Russia, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: North America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: North America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: North America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: USA, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: USA, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: USA, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: Canada, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: Canada, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: Canada, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: South America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: South America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: South America, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Brazil, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: Brazil, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: Brazil, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: Middle East, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Middle East, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Middle East, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Africa, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Africa, Colorectal Cancer Molecular Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Africa, Colorectal Cancer Molecular Diagnostics Market, Segmentation By End Users, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Global Colorectal Cancer Molecular Diagnostics Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 96: Global Colorectal Cancer Molecular Diagnostics Market - Company Scoring Matrix
  • Figure 97: Johnson & Johnson Financial Performance
  • Figure 98: Bayer AG Financial Performance
  • Figure 99: Abbott Laboratories Financial Performance
  • Figure 100: Danaher Corporation Financial Performance
  • Figure 101: Becton Dickinson and Company Financial Performance
  • Figure 102: Global Colorectal Cancer Molecular Diagnostics Market, Competitive Benchmarking (In USD Billions)
  • Figure 103: Global Colorectal Cancer Molecular Diagnostics Market, Competitive Dashboard
  • Figure 104: Global Colorectal Cancer Molecular Diagnostics Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 105: Global, Colorectal Cancer Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Type, 2025 – 2030
  • Figure 106: Global, Colorectal Cancer Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By Technology, 2025 – 2030
  • Figure 107: Global, Colorectal Cancer Molecular Diagnostics Market Size Gain ($ Billion), Segmentation By End Users, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

Read More About A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Read More About A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Colorectal Cancer Molecular Diagnostics Market Report 2026 - Global Outlook – By Type (Instruments, Reagents And Kits, Services), By Technology (Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcripti...

Cancer Diagnostics Market Report 2026 - Global Outlook – By Products (Companion Diagnostics, Molecular Diagnostics), By Method (Biopsy, Endoscopy, Tumor Biomarker Tests, Imaging), By Application (Cervical Cancer, Breast ...

Colorectal Cancer Drugs Market Report 2026 - Global Outlook – By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1 Or PD1 Liga...

Pancreatic Cancer Diagnostic Market Report 2026 - Global Outlook – By Product (Instruments, Consumables, Services), By Treatment (Surgery, Chemotherapy, Radiation Therapy, Targeted Therapy), By Cancer Type (Exocrine, Ade...

Point-Of-Care Molecular Diagnostics Market Report 2026 - Global Outlook – By Product (Assays And Kits, Instruments And Analyzers), By Application (Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted...

Cancer Tumor Profiling Market Report 2026 - Global Outlook – By Cancer Type (Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Melanoma, Ovarian Cancer, Stomach Cancer, Pancreatic Cancer, Thyroid Cancer, Ot...

Liver Cancer Diagnostics Market Report 2026 - Global Outlook – By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma), By Screening (Laboratory Testing, Imaging, Biopsy, Other Screenings), By Technology (...

Liquid Biopsy For Cancer Diagnostics Market Report 2026 - Global Outlook – By Type (Product, Services), By Sample (Blood, Urine, Saliva), By Cancer (Lung Cancer, Breast Cancer, Colon Cancer, Other Cancers), By End-User (...

Frequently Asked Questions

The Colorectal Cancer Molecular Diagnostics Market Report 2026 market was valued at $2.78 billion in 2025, increased to $3.02 billion in 2026, and is projected to reach $4.15 billion by 2030. request a sample here

The expected CAGR for the Colorectal Cancer Molecular Diagnostics Market Report 2026 market during the forecast period 2025–2030 is 8.3%. request a sample here

Major growth driver of the market includes: The Impact Of Increasing Colorectal Cancer Prevalence On The Colorectal Cancer Molecular Diagnostics Market in the Colorectal Cancer Molecular Diagnostics Market Report 2026 market. For further insights on this market, request a sample here

The colorectal cancer molecular diagnostics market covered in this report is segmented –
1) By Type: Instruments, Reagents And Kits, Services
2) By Technology: Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcription Mediated Amplification, Chips And Microarrays, Isothermal Nucleic Acid Amplification Technology (INAAT)
3) By End Users: Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Homecare Settings Subsegments:
1) By Instruments: PCR Machines, Sequencers, Microarrays
2) By Reagents And Kits: DNA Or RNA Extraction Kits, Assay Kits, Reagent Packs
3) By Services: Diagnostic Testing Services, Genetic Testing Services, Consultation Services request a sample here

Major trend in this market includes: Advancements in Non-Invasive Early Detection for Colorectal Cancer For further insights on this market, request a sample here.

Major companies operating in the Colorectal Cancer Molecular Diagnostics Market Report 2026 market are Major companies operating in the colorectal cancer molecular diagnostics market are Johnson & Johnson, Bayer AG, Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, Biocartis Group NV, Agilent Technologies Inc., Grifols S.A, Hologic Inc., Biomérieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corporation, Illumina Inc., Cepheid, Myriad Genetics Inc., Guardant Health, Luminex Corporation, GenMark Diagnostics, Amoy Diagnostics Co. Ltd., MDxHealth Inc., HTG Molecular Diagnostics Inc., GenPath Diagnostics, geneOmbio Technologies Pvt. request a sample here.

North America was the largest region in the colorectal cancer molecular diagnostics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the colorectal cancer molecular diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us